Medicenna Therapeutics Ownership | Who Owns Medicenna Therapeutics?


OverviewChart

Medicenna Therapeutics Ownership Summary


Medicenna Therapeutics is owned by 0.19% institutional investors, and 99.81% retail investors. Purpose Special Opportunities Series A is the top mutual fund, with 0.03% of its assets in Medicenna Therapeutics shares.

MDNA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMedicenna Therapeutics0.19%-99.81%
SectorHealthcare Stocks 47.38%7.99%44.63%
IndustryBiotech Stocks 45.43%7.81%46.75%

Institutional Shareholders


Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20233-88.00%128,978-98.44%-0.13%1-85.71%--100.00%
Sep 30, 202325-3.85%8,281,040-3.91%117.76%716.67%6-14.29%
Jun 30, 202326-8,617,865-1.65%127.80%620.00%716.67%
Mar 31, 202326-3.70%8,762,397-8.71%126.63%5-58.33%6100.00%
Dec 31, 202227-3.57%9,598,439-1.94%135.81%12-33.33%3-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Purpose Special Opportunities Series A20.13K0.03%-

Recent Insider Transactions


DateNameRoleActivityValue

Insider Transactions Trends


DateBuySell

MDNA Ownership FAQ


Who Owns Medicenna Therapeutics?

Medicenna Therapeutics shareholders are primarily institutional investors at 0.19%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Medicenna Therapeutics's industry, Biotech Stocks , is 45.43%, which Medicenna Therapeutics falls below.

Does Blackrock own Medicenna Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Medicenna Therapeutics.

Who is the top mutual fund holder of Medicenna Therapeutics shares?

Purpose Special Opportunities Series A is the top mutual fund holder of Medicenna Therapeutics shares, with 0.03% of its total shares outstanding invested in 20.13K Medicenna Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools